As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Though you can hit speed bumps in your weight loss journey, Hone Health says there are minor tweaks you can make to get your ...

The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and ...

Sean and I are expecting our third child, which we’re so excited about,” the former White House press secretary said live on ...

Jaime King’s ex-husband Kyle Newman was awarded sole physical custody of their two sons after the actress was ordered to a ...

The Trump administration earlier this year ordered all government employees to return to work in person. FDA employees whose ...

You heard it here first—it’s time to hit the ground running for the 2025 SELF Sneaker Awards. Year after year, SELF’s Sneaker ...

The new $5.3 billion deal with the Swiss pharma giant gives Zealand a significant partner to advance its amylin analog obesity shot and create a new combination product.

Year 2024 Revenue Reached RMB39,241 Million, Up 5.2% Year-over-Year (Excluding COVID-19 Commercial Project of 2023) Full-Year Net Profit Attributable to the Owners of the Company Reached RMB9,450 ...